Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | LASA Lasa Supergenerics Limited Pharma · Small | MEDIORG Medicamen Organics Ltd. Pharma · SME | INFINIUM Infinium Pharmachem Ltd. Pharma · SME | SAROJA Saroja Pharma Industries India Ltd. Pharma · SME |
|---|---|---|---|---|
| Final Score | 5 | 13 | 49 | 49 |
| Verdict | OVERVALUED | OVERVALUED | FAIR VALUE | FAIR VALUE |
| Style | Distress Watch | Distress Watch | Financial Turnaround | Deep Value |
| Piotroski | 2/9 | 4/9 | 8/9 | 6/9 |
| Valuation | 5/30 | 5/30 | 10/30 | 30/30 |
| Growth | 0/25 | 10/25 | 16/25 | 15/25 |
| Quality | 0/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 5/15 | 4/15 | 12/15 | 7/15 |
| Cash Flow | 3/10 | 0/10 | 8/10 | 1/10 |
| Price | ₹7.61 | ₹20 | ₹206.75 | ₹33.95 |
| P/E | — | — | 26.20 | 8.43 |
| P/B | 0.78 | 0.89 | 2.63 | 0.79 |
| ROE | -19.60% | -13.70% | 10.50% | 9.83% |
| ROCE | -18.20% | -10.70% | 13.10% | 13.00% |
| Debt / Equity | 0.20 | 0.50 | 0.00 | 0.83 |
| FCF Yield | — | — | 8.49% | — |
| Dividend Y | — | — | — | — |
| Altman Z | 1.73 | 1.52 | 6.12 | 2.91 |
| Promoter % | 53.65% | 59.73% | 64.91% | 73.02% |
| Mkt Cap (₹Cr) | 38.20 | 25.60 | 318.00 | 13.60 |
| Graham # | — | — | ₹116.77 | ₹62.44 |
| Fair PE | 1.3 | 42.0 | 42.0 | 42.0 |
| MoS % | — | — | +36.9% | +80.0% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startLASA27
MEDIORG15
INFINIUM83
SAROJA86